Driving Healthcare Innovation: A Conversation with Nidhi Shashikumar
Nidhi Shashikumar is a data scientist and business intelligence expert with over 7 years of experience in healthcare ...
Zacks Investment Research on MSN12h
Gilead Sciences (GILD) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Gilead Sciences (GILD) closed at $106.67, marking a -0.38% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 1.77% for the day.
UNAIDS director proposes that President Trump make an 'amazing deal' to end HIV
The head of the U.N. AIDS agency says the sudden loss of American money has been “devastating” for efforts to stop HIV and ...
RBC Capital Sticks to Its Hold Rating for Gilead Sciences (GILD)
RBC Capital analyst Brian Abrahams maintained a Hold rating on Gilead Sciences (GILD – Research Report) today and set a price target of $90.00.